Podcasts about guidelines

Today, we continue our review of the Global Initiative for Asthma (GINA) guidelines on asthma. We've covered asthma diagnosis and phenotyping, and the initial approach to therapy. On today's episode we're talking about biologic therapies for asthma and will cover … Continue reading →

In this episode, hosts Drs. Peter Lu and Temara Hajjat talk to Dr. Thangam Venkatesan about cannabinoid hyperemesis syndrome (CHS).  Dr. Venkatesan is an adult gastroenterologist and Professor of Internal Medicine at The Ohio State University Wexner Medical Center, where she leads the Neurogastroenterology and Motility section.  She is a world-renowned expert in CHS and cyclic vomiting syndrome (CVS).  In this episode, we discuss the diagnosis of CHS, its relationship with CVS, and the management of the adolescent with CHS. Learning Objectives:Understand the diagnostic criteria for cannabinoid hyperemesis syndrome (CHS).Recognize the similarities and differences between CHS and cyclic vomiting syndrome.Review the management of the adolescent with CHS.Links:Venkatesan T, et al. Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association. Neurogastroenterol Motil. 2019 Jun;31 Suppl 2(Suppl 2):e13604. PMID: 31241819Support the showThis episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

Do you have a class full of wiggle worms? It might be time to rethink how you're using movement in the classroom! We're sharing five easy and effective ways to add movement to lessons without losing valuable instructional time. These simple strategies help channel student energy into purposeful learning, improve focus, and even reduce behavior issues—turning your classroom into a more engaging and dynamic space. Whether it's interactive comprehension checks or quick brain breaks, you'll walk away with practical ideas to make movement a powerful part of your teaching routine!Prefer to read? Grab the episode transcript and all resources mentioned in the show notes here: https://www.secondstorywindow.net/podcast/add-movement-to-lessons/Resources:Printable Brain Break ActivitiesNeuro-Mag Magnesium L-ThreonateConnect with us on Instagram @2ndstorywindow.Shop our teacher-approved resources.Join our Teacher Approved Facebook group.Leave a review on Apple Podcasts!Related Episodes to Enjoy:Episode 163, The 6 Key Ways to Boost Student Engagement Every DayEpisode 50, 3 Guidelines to Make Classroom Transitions Work Smarter No HarderEpisode 49, Rapid Classroom Transitions: How to Save 45 Hours a YearEpisode 48, How to Make Classroom Transitions Simple With Clear Beginnings and EndingsMentioned in this episode:If you're enjoying this podcast, we would love to hear from you! You can leave a rating and review on Apple Podcasts: https://podcasts.apple.com/us/podcast/teacher-approved/id1613980327

Send us a textIt's been nearly two decades since the last Canadian clinical practice guideline on managing obesity in children. In that time, the science has advanced, treatment options have expanded, and the need for updated guidance has grown increasingly urgent. On this episode of the CMAJ Podcast, hosts Dr. Mojola Omole and Dr. Blair Bigham speak with three guests who contributed to or were impacted by the new guideline published in CMAJ. Together, they explore how the recommendations address the complexity of pediatric obesity and what it takes to implement them in real-world settings.Dr. Geoff Ball, chair of the guideline steering committee, explains how the recommendations were shaped by evidence as well as the meaningful participation of parents and youth at every stage of development. He discusses how the panel weighed the benefits and risks of pharmacotherapy and bariatric surgery in the context of limited pediatric data and a rapidly evolving treatment landscape.Dr. Michelle Jackman, a pediatrician and clinical lead at the Pediatric Centre for Wellness and Health in Calgary, shares how her team delivers multi-component behavioural interventions, often in the absence of system-wide supports. She reflects on how the new guideline has prompted her to reconsider referral pathways for bariatric surgery and advocate more strongly for patients.Brenndon Goodman, a long-time patient advocate, offers his own experience navigating childhood obesity, including the emotional dimensions of eating, the impact of stigma, and the life-changing outcome of bariatric surgery. He calls for improved access to care and a stronger commitment to children and youth living with obesity.This episode highlights both the progress and the persistent barriers in treating childhood obesity. The new guideline affirms that obesity is a complex chronic condition and provides much-needed support for physicians caring for children and youth living with it.For more information from our sponsor, go to scotiabank.com/physicians.Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.You can find Blair and Mojola on X @BlairBigham and @DrmojolaomoleX (in English): @CMAJ X (en français): @JAMC FacebookInstagram: @CMAJ.ca The CMAJ Podcast is produced by PodCraft Productions

In this 'EPISODE 409 GOOD NEWS JESUS IS COMING! WILL HE COME SOON IN OUR TIME? WHAT DOES THE BIBLE PREDICT ABOUT THE FUTURE OF THE MIDDLE EAST? WHERE DOES IT MENTION THE KINGDOM OF GOD?' author and host Elbert Hardy of itellwhy.com, shows us scriptures from the Old Testament and New Testament that give us guidelines about the hour of his coming.Go to itellwhy.com to read Elbert's books free of charge, no Ads and no requests for money or Email addresses. You can watch faith building YouTube Links to Videos and the listen to Elbert's Life of Christ Audio Book in 30 minute Episodes arranged and read by the author straight from the Bible, but rearranged in logical harmony of the Gospels, Revelation and other scriptures. All FREE of charge in the public interest.

Welcome back to this week's Friday Review where we'll be covering the very best of the week including reviewing these topics:     Krazy Klean Toilet Cleaner (product review) Dissolving Illusions (book review) Vitamin-D Guidelines (research) Plants & Inflammation (research)     For all the details tune into today's Cabral Concept 3360 – Enjoy the show and let me know what you thought!     - - - For Everything Mentioned In Today's Show: StephenCabral.com/3360 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!  

In today's episode, Pastor Todd and Katie Holmes continue to talk about relationships and how to avoid wasting time and energy on the person that God has for you. Often times we are looking for someone that doesn't exist or a person based off of what other people think we need, but God knows exactly who is best for you. Get to a place where you are addressing the potential hindrances in your relationship life and how God can help you get to the place to be ready for that special person in your life.NEW EPISODES every Monday & Friday @ Noon.https://www.facebook.com/TheRiverOfTriCities/https://www.youtube.com/@TheRiverofTriCitiesChurchhttps://www.instagram.com/rivertcchurch/?hl=enhttps://www.instagram.com/thelastdayspodcast/?hl=en

keywords Ecstatic Dance, Wellness, Community, Movement, Healing, Mindfulness, Dance Therapy, Sober Dance, Emotional Expression, Personal Growth, dance, community, healing, connection, COVID, ecstatic dance, self-expression, mental health, joy, transformation summary In this conversation, Jane Garnett and Robin Parrish explore the transformative practice of ecstatic dance, discussing its origins, guidelines, and therapeutic benefits. Robin shares his personal journey with ecstatic dance, emphasizing the importance of community, consent, and emotional expression in this unique form of movement. The discussion highlights how ecstatic dance serves as a permission slip for individuals to connect with themselves and others, fostering a sense of belonging and healing. In this conversation, Robin Parrish discusses the transformative power of dance as a means of healing, connection, and self-expression. He reflects on the evolution of ecstatic dance, especially during the COVID pandemic, and emphasizes the importance of community and the psychological benefits of movement. The dialogue explores how dance serves as a metaphor for life, encouraging individuals to embrace their authentic selves and foster connections with others. Ultimately, the conversation highlights the joy and celebration that dance brings to our lives, advocating for a world where everyone can dance freely and joyfully together. takeaways Ecstatic dance is a modern-day ritual for community connection. The practice encourages moving freely and authentically without judgment. Sober environments enhance the experience of ecstatic dance. Consent is crucial in nonverbal spaces like dance floors. Ecstatic dance can serve as a form of group therapy. The intensity of dance can be both confronting and liberating. Personal growth often occurs through the practice of ecstatic dance. Dance allows for emotional expression and release. The guidelines of ecstatic dance create a safe space for participants. Ecstatic dance is a celebration of life and human connection. Dance is a powerful expression and metaphor for life. The practice of dance helps reconnect us with our bodies. Dancing can be a form of healing and self-discovery. Community is essential for the practice of ecstatic dance. Dance can adapt to changing circumstances, such as during COVID. The psychological benefits of dance include reducing self-judgment. Dancing together fosters a sense of connection and unity. It's important to focus on how dance feels rather than how it looks. Dance can help us unlearn limiting beliefs about ourselves. Celebrating life through dance can bring joy and transformation. titles The Healing Power of Ecstatic Dance Exploring the Guidelines of Ecstatic Dance Ecstatic Dance: A Journey of Self-Discovery The Community Ritual of Ecstatic Dance Sound Bites "No drugs or alcohol in the space." "It's like a big form of group therapy." "It's a miracle that we even exist." "Dance is like shaking it up literally." "It felt like home." "I just want us to celebrate life." "Let's dance out of limiting beliefs." "We are the performance, we are art." "Dance is a celebration of life." Chapters 00:00 Introduction to Ecstatic Dance 02:57 Guidelines and Principles of Ecstatic Dance 10:03 The Therapeutic Aspects of Ecstatic Dance 18:12 Personal Journey with Ecstatic Dance 26:40 The Healing Power of Dance 29:33 Adapting to Change: Dance During COVID 31:52 Dance as a Metaphor for Connection 36:00 The Psychological Benefits of Dance 39:45 Creating Community Through Dance 46:01 The Heart Party: Celebrating Life Together Learn more about your ad choices. Visit podcastchoices.com/adchoices

When it comes to tackling fertility issues associated with cancer, “oncology clinicians are often reluctant to talk about this because it is really not our wheelhouse,” says Alison Wakoff Loren, MD, MSCE, chief of the Division of Hematology Oncology, director of Blood and Bone Marrow Transplantation, and the C. Willard Robinson Professor of Hematology-Oncology at Penn Medicine in Philadelphia. Dr. Loren and colleagues recently updated American Society of Clinical Oncology guidelines for fertility preservation in people with cancer. She discusses the key changes with Robert Figlin, MD, interim director at Cedars Sinai Cancer Center in Los Angeles and the Steven Spielberg Family Chair in Hematology-Oncology. “This is a really important topic that I think sometimes gets lost in the shuffle of the hecticness of a young person's cancer diagnosis,” Dr. Loren explains. Increased awareness among oncologists is a crucial step that can lead to faster referrals and interventions, she says. “You better be ready for the conversation,” she urges. Dr. Loren reported research funding from Equillium (Inst). Dr. Figlin reported various financial relationships.

In today's VETgirl online veterinary CE podcast, we interview Dr. Chris Adolph, MS, ACVM on the latest American Heartworm Society (AHS) guidelines on feline heartworm management. Tune in to hear about the latest methods for diagnosis and preventing feline heartworm disease!Sponsored By: American Heartworm Society

Not long ago, 36 allergy experts worldwide came together to develop a consensus on preparing their patients for Oral Immunotherapy, also known as OIT. We're sitting down with FAACT's Medical Advisory Board Member, Dr. Katherine Anagnostou, one of the 36 allergy experts collaborating in the Preparing Patients for Oral Immunotherapy (PPOINT) consensus. Resources to keep you in the know:Preparing Patients for Oral Immunotherapy (PPOINT): international Delphi consensus for procedural preparation and consent - Journal of Allergy and Clinical ImmunologyYou can find FAACT's Roundtable Podcast on Apple Podcasts, Pandora, Spotify, Podbay, iHeart Radio, or wherever you listen to podcasts.Follow us on Facebook, Instagram, BlueSky, Threads, LinkedIn, Pinterest, TikTok, and YouTube.Thanks for listening! FAACT invites you to discover more exciting food allergy resources at FoodAllergyAwareness.org!

What role does craniofacial growth play in childhood sleep health? Dr. Loria Nahatis, pediatric dentist from Beyond Pediatric Dentistry in Dallas, Texas, discusses the importance of early intervention in pediatric dentistry, focusing on evaluating and treating children with sleep disordered breathing. --- SYNPOSIS Dr. Nahatis shares her personal experience with her daughter and how noticing sleep-related issues shifted her focus in dental practice. Dr. Nahatis covers various treatment methods such as habit correctors, palatal expanders, and myofunctional therapy. The podcast emphasizes the importance of interdisciplinary collaboration between dentists, ENTs, and other healthcare providers to improve patient outcomes. Key points include the significance of nasal breathing, conservative treatment options, and the impact of jaw and dental structure on overall health. --- TIMESTAMPS 00:00 - The Importance of Screening for Sleep Disorders in Children 06:26 - Treatment Options and Approaches 10:29 - Guidelines and Policies on Sleep Disorders 19:42 - Teeth Grinding and Myofunctional Therapy 27:32 - Imaging and Evaluation Techniques 29:01 - Surgical Considerations and Early Interventions 36:44 - Counseling Families on Oral Appliances 50:12 - Insurance and Cost Considerations 56:15 - Collaborative Approaches and Final Thoughts --- RESOURCES Dr. Loria Nahatis's practice profile: https://beyondpediatricdentistry.com/dr-loria-nahatis-dds/

In this episode of PT Snacks podcast, host Kasey discusses the relationship between exercise and diabetes, specifically aimed at physical therapists and students. The episode covers the different types of diabetes (Type 1, Type 2, and gestational), and how exercise influences blood sugar levels. It also highlights the effects of various diabetes medications on exercise and provides practical tips for safely managing patients with diabetes in a physical therapy setting. Additionally, useful resources and courses are recommended for further learning.00:00 Introduction to PT Snacks Podcast00:46 Understanding Diabetes and Exercise01:47 Types of Diabetes and Their Impact on Exercise03:21 Diabetes Medications and Exercise Considerations04:59 Guidelines for Safe Exercise with Diabetes06:04 Red Flags and Patient Communication06:57 Additional Resources and ConclusionRelevant MedBridge Courses1. Exercise and Drug Interactions – Kenneth L. Miller2. Managing Patients with Diabetes – Kathy Shimp, PT, DPTSupport the showWhy PT Snacks Podcast?This podcast is your go-to for bite-sized, practical info designed for busy, overwhelmed Physical Therapists and students who want to build confidence in their foundational knowledge without sacrificing life's other priorities. Stay Connected! Never miss an episode—hit follow now! Got questions? Email me at ptsnackspodcast@gmail.com or leave feedback HERE. Join the email list HERE On Instagram? Find unique content at @dr.kasey.hankins! Need CEUs Fast?Time and resources short? Medbridge has you covered: Get over $100 off a subscription with code PTSNACKSPODCAST: Medbridge Students: Save $75 off a student subscription with code PTSNACKSPODCASTSTUDENT—a full year of unlimited access for less!(These are affiliate links, but I only recommend Medbridge because it's genuinely valuable.) Optimize Your Patient Care with Tindeq Looking for a reliable dynamometer to enhance your clinical measurements? Tindeq ...

April 14, 2025Have you had your dose of The Daily MoJo today? Download our app HERE"Ep 041425: Calling In Sick - The Daily MoJo"Participants express excitement for an upcoming event while discussing legal issues surrounding the Epstein case, including a lawsuit for client lists. Concerns about the investigation's integrity arise, alongside a report of a threat against President Trump. The content also covers health risks of brown rice due to arsenic, the evolution of dietary guidelines, and a rocket launch highlighting safety in space travel and private sector advancements.Phil Bell's Morning Update - The government is NOT a genie in a bottle:  HEREOur affiliate partners:Pantell Less Lethal Protection - an official dealer of Byrna Technologies - has your alternative to deadly force. It's the Byrna Launcher, and it's legal in all 50 states! Check your state's laws for any special restrictions that may exist. Find the Byrna Launcher that's perfect for you: ProtectMyMojo.comPromo Code: dailymojoRoss's Cell: 908.642.2636Romika Designs is an awesome American small business that specializes in creating laser-engraved gifts and awards for you, your family, and your employees. Want something special for someone special? Find exactly what you want at MoJoLaserPros.com  There have been a lot of imitators, but there's only OG – American Pride Roasters Coffee. It was first and remains the best roaster of fine coffee beans from around the world. You like coffee? You'll love American Pride – from the heart of the heartland – Des Moines, Iowa. AmericanPrideRoasters.com   Find great deals on American-made products at MoJoMyPillow.com. Mike Lindell – a true patriot in our eyes – puts his money where his mouth (and products) is/are. Find tremendous deals at MoJoMyPillow.com – Promo Code: MoJo50  Life gets messy – sometimes really messy. Be ready for the next mess with survival food and tools from My Patriot Supply. A 25 year shelf life and fantastic variety are just the beginning of the long list of reasons to get your emergency rations at PrepareWithMoJo50.comStay ConnectedWATCH The Daily Mojo LIVE 7-9a CT: www.TheDailyMojo.com (RECOMMEDED)Rumble: HEREFacebook: HEREMojo 5-0 TV: HEREFreedomsquare: HEREOr just LISTEN:The Daily MoJo Channel Become a supporter of this podcast: https://www.spreaker.com/podcast/the-daily-mojo-with-brad-staggs--3085897/support.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-428 Overview: Stay ahead in stroke prevention with the latest guidelines. In this episode, we cover new considerations for social determinants of health, interventions across the lifespan, and evidence-based strategies to reduce stroke risk. Learn how to integrate these updates into primary care for more effective patient outcomes. Episode resource links: Bushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., 3rd, Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O., Levine, D. A., Love, M., Miller, E., Nguyen-Huynh, M., Rasmussen-Winkler, J., Rexrode, K. M., Rosendale, N., Sarma, S., Shimbo, D., Simpkins, A. N., … Whelton, P. K. (2024). 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association. Stroke, 55(12), e344–e424. https://doi.org/10.1161/STR.0000000000000475 Ravichandran, S., Gajjar, P., Walker, M. E., Prescott, B., Tsao, C. W., Jha, M., Rao, P., Miller, P., Larson, M. G., Vasan, R. S., Shah, R. V., Xanthakis, V., Lewis, G. D., & Nayor, M. (2024). Life's Essential 8 Cardiovascular Health Score and Cardiorespiratory Fitness in the Community. Journal of the American Heart Association, 13(9), e032944. https://doi.org/10.1161/JAHA.123.032944 Kumar, M., Orkaby, A., Tighe, C., Villareal, D. T., Billingsley, H., Nanna, M. G., Kwak, M. J., Rohant, N., Patel, S., Goyal, P., Hummel, S., Al-Malouf, C., Kolimas, A., Krishnaswami, A., Rich, M. W., Kirkpatrick, J., Damluji, A. A., Kuchel, G. A., Forman, D. E., & Alexander, K. P. (2023). Life's Essential 8: Optimizing Health in Older Adults. JACC. Advances, 2(7), 100560. https://doi.org/10.1016/j.jacadv.2023.100560 Life's Essential 8 tools for providers and patient information: https://www.heart.org/en/healthy-living/healthy-lifestyle/lifes-essential-8 Guest: Jill M. Terrien PhD, ANP-BC   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com   

April might seem early to prep for next school year, but it's actually the perfect time to take on some manageable tasks that'll make back-to-school season way less overwhelming. In this episode, we're sharing five smart and practical things to do in April for back-to-school. You'll learn why April is ideal for this kind of prep, how to prioritize without adding stress, and how these small moves can help you enjoy summer a bit more!Prefer to read? Grab the episode transcript and all resources mentioned in the show notes here: https://www.secondstorywindow.net/podcast/to-do-in-april-for-back-to-school/Resources:Freebie: End-of-Year Road MapProcedure Review SlidesFirst Lie WinsLa Roche Posay Effaclar Gel CleanserEpisode 154, 5 Steps for Classroom Procedure SuccessEpisode 150, Perfect Your Classroom Procedures With the Help of Our Guiding QuesitonsEpisode 50, 3 Guidelines to Make Classroom Transitions Work Smarter Not HarderEpisode 49, Rapid Classroom Transitions: How to Save 45 Hours a YearEpisode 48, How to Make Classroom Transitions Simple With Clear Beginning and EndingsEpisode 32, 5 Classroom Management Questions to Help Banish Bad Class HabitsConnect with us on Instagram @2ndstorywindow.Shop our teacher-approved resources.Join our Facebook group, Teacher ApprovedLeave your review on Apple Podcasts!More Related Episodes to Enjoy:Episode 158, Back-to-School Classroom Management: Are You Working Smarter or Harder?Episode 153, How Teachers Can Thrive During the Back-to-School Season - Our Best StrategiesEpisode 135, Treat Yourself! Make a Back-to-School Teacher Self-Care PlanMentioned in this episode:If you're...

In today's episode, Pastor Todd and Katie Holmes talk about relationships and how to avoid wasting time and energy on the person that God has for you. Often times we are looking for someone that doesn't exist or a person based off of what other people think we need, but God knows exactly who is best for you. Get to a place where you are addressing the potential hindrances in your relationship life and how God can help you get to the place to be ready for that special person in your life.NEW EPISODES every Monday & Friday @ Noon.https://www.facebook.com/TheRiverOfTriCities/https://www.youtube.com/@TheRiverofTriCitiesChurchhttps://www.instagram.com/rivertcchurch/?hl=enhttps://www.instagram.com/thelastdayspodcast/?hl=en

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-428 Overview: Stay ahead in stroke prevention with the latest guidelines. In this episode, we cover new considerations for social determinants of health, interventions across the lifespan, and evidence-based strategies to reduce stroke risk. Learn how to integrate these updates into primary care for more effective patient outcomes. Episode resource links: Bushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., 3rd, Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O., Levine, D. A., Love, M., Miller, E., Nguyen-Huynh, M., Rasmussen-Winkler, J., Rexrode, K. M., Rosendale, N., Sarma, S., Shimbo, D., Simpkins, A. N., … Whelton, P. K. (2024). 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association. Stroke, 55(12), e344–e424. https://doi.org/10.1161/STR.0000000000000475 Ravichandran, S., Gajjar, P., Walker, M. E., Prescott, B., Tsao, C. W., Jha, M., Rao, P., Miller, P., Larson, M. G., Vasan, R. S., Shah, R. V., Xanthakis, V., Lewis, G. D., & Nayor, M. (2024). Life's Essential 8 Cardiovascular Health Score and Cardiorespiratory Fitness in the Community. Journal of the American Heart Association, 13(9), e032944. https://doi.org/10.1161/JAHA.123.032944 Kumar, M., Orkaby, A., Tighe, C., Villareal, D. T., Billingsley, H., Nanna, M. G., Kwak, M. J., Rohant, N., Patel, S., Goyal, P., Hummel, S., Al-Malouf, C., Kolimas, A., Krishnaswami, A., Rich, M. W., Kirkpatrick, J., Damluji, A. A., Kuchel, G. A., Forman, D. E., & Alexander, K. P. (2023). Life's Essential 8: Optimizing Health in Older Adults. JACC. Advances, 2(7), 100560. https://doi.org/10.1016/j.jacadv.2023.100560 Life's Essential 8 tools for providers and patient information: https://www.heart.org/en/healthy-living/healthy-lifestyle/lifes-essential-8 Guest: Jill M. Terrien PhD, ANP-BC   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com   

In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Aaron Bleznak the results of a comparison of guideline-concordant surgery, which is modified radical mastectomy without immediate reconstruction following chemotherapy, for lobular versus ductal inflammatory breast cancer, as reported in their article, "Guideline-Concordant Surgical Care for Lobular Versus Ductal Inflammatory Breast Cancer.”

If you've ever walked out of a doctor's office feeling more confused than when you walked in, you're not alone. Many people with PCOS are left in the dark when it comes to getting a proper diagnosis, navigating treatment options, and knowing what steps to take next. In this episode, we break down the most important tests and investigations for PCOS, what they actually tell you, and why a diagnosis is just the beginning. We'll also talk about why treatment can feel frustrating or slow.More importantly, you'll learn what actions you can take to move forward - whether your goals are better energy, regular cycles, improved digestion, or long-term health protection.If this episode resonated with you, we'd love for you to share it with someone who needs it and leave us a review!Links: PCOS Recovery Program - April 23  How PCOS can create gender euphoria for trans and nonbinary people  ReferencesBrown, S. J. (2022, October 26). How PCOS can create gender euphoria for trans and nonbinary people. Prism Reports.Helena Teede et al. International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023. Monash University. Himmelstein MS, Puhl RM, Quinn DM. Intersectionality: An Understudied Framework for Addressing Weight Stigma. Am J Prev Med 2017;53:421-31.

What if the secret to better health isn't just what you eat, but when you eat? In this episode, we sit down with renowned circadian biology expert Dr. Satchin Panda to explore the science behind time-restricted eating, body clocks, and how your daily routines can transform your metabolism, sleep, and overall well-being. From groundbreaking mouse studies to practical human applications, Dr. Panda breaks it all down in a way that's eye-opening and actionable.About SparX by Mukesh BansalSparX is a podcast where we delve into cutting-edge scientific research, stories from impact-makers and tools for unlocking the secrets to human potential and growth. We believe that entrepreneurship, fitness and the science of productivity is at the forefront of the India Story; the country is at the cusp of greatness and at SparX, we wish to make these tools accessible for every generation of Indians to be able to make the most of the opportunities around us. In a new episode every Saturday, our host Mukesh Bansal (Founder of Myntra and Cult.fit) will talk to guests from all walks of life and also break down everything he's learnt about the science of impact over the course of his 20-year long career. This is the India Century, and we're enthusiastic to start this journey with you.Follow us on our Instagram: / sparxbymukeshbansal Also check out our website: https://www.sparxbymukeshbansal.com You can also listen to SparX on all audio platforms!Fasion | Outbreak | Courtesy EpidemicSound.com

On this episode we review the 2025 Clinical Practice Guideline for the Pharmacologic Management of Adults with Dyslipidemia published by the American Association of Clinical Endocrinology. We compare and contrast the common medications used in the management of dyslipidemia and examine how these can be utilized based on the 13 updated recommendations found in the 2025 guidelines.  Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

In today's episode, Pastor Todd and Katie Holmes talk about relationships and how to avoid wasting time and energy on the person that God has for you. Often times we are looking for someone that doesn't exist or a person based off of what other people think we need, but God knows exactly who is best for you. Get to a place where you are addressing the potential hindrances in your relationship life and how God can help you get to the place to be ready for that special person in your life.NEW EPISODES every Monday & Friday @ Noon.https://www.facebook.com/TheRiverOfTriCities/https://www.youtube.com/@TheRiverofTriCitiesChurchhttps://www.instagram.com/rivertcchurch/?hl=enhttps://www.instagram.com/thelastdayspodcast/?hl=en

In Episode 49, co-hosts Dr. Hanaa Almoaibed and Lucien Zeigler catch up after a short break over the Eid holidays before jumping into a DEEPDIVE on Saudi Arabia's new architectural guidelines, released by HRH the Crown Prince (along with a map!). Saudi Arabia is identifying and solidifying its heritage through new urban development guidelines that incorporate the kingdom's indigenous design traditions. The initiative will serve as a guideline for developers, Saudi real estate businesses, and urban planning projects, ensuring that new developments complement their surroundings while integrating traditional architectural elements into modern designs. The hosts discuss - and applaud - this move, as fans of architecture and especially with all of the unique looks that Saudi Arabia has to offer.  The hosts then get to the latest news, and discuss Telsa's market entry into Saudi Arabia, President Trump's Iftar dinner with HRH Princess Reema before the conclusion of Ramadan, and more. 

In this episode, we start a new building block of our social protection solar system with the first part of the topic on delivery and provision of social protection. We will be looking at the innovations in the delivery of services and cash grants, focusing on informal workers and on the role that informal workers organizations might have in improving access to these workers by facilitating the last mile delivery of services or benefits. To open this block, we will turn to Africa and look into three cases of provision of child care services. First, we go to South Africa, to talk to Richard Dobson about the pop-up child care facility in the Warwick Junction market, in Durban. Richard is an architect and co-founder of the NGO Asiye eTafuleni. Next, we move to Accra, in Ghana, to talk to Dorcas Ansah, WIEGO's Accra Focal city coordinator. We discussed the guidelines for implementing child care facilities in the Ghanaian capital markets and the plans for expanding the initiative. We finish our tour in Rwanda, where the market vendors association SITRIECY is also implementing child care facilities in the Kigali markets. We talked to SITRIECY's secretary-general and StreetNet International treasurer Jeanette Nyiramassengesho. She explained their approach to combine provision of child care for informal workers' children in markets with the creation of a community savings group. *** Learn more - WIEGO: Child Care in Markets: An E-Book https://www.wiego.org/research-library-publications/child-care-in-markets/ - Working in Warwick: Including Street Traders in Urban Plans https://www.wiego.org/research-library-publications/working-warwick-including-street-traders-urban-plans/ - WIEGO - Child Care in Markets project: https://www.wiego.org/project/child-care-markets/ - Guidelines and Standards for Day-Care Centres in and around Markets in Ghana, by Susan Sabaa, Dela Quarshie-Twum https://www.wiego.org/advocacy-worker-education-resources/guidelines-and-standards-day-care-centres-and-around-markets-ghana/ - Webinar: https://www.youtube.com/watch?v=wn9niHLL8vI - About Asiye eTafuleni https://aet.org.za/about-asiye-etafuleni/our-story/

Getting Past PyArmor PyArmor is a python obfuscation tool used for malicious and non-malicious software. Xavier is taking a look at a sample to show what can be learned from these obfuscated samples with not too much work. https://isc.sans.edu/diary/Obfuscated%20Malicious%20Python%20Scripts%20with%20PyArmor/31840 CenterStack RCE CVE-2025-30406 Gladinet s CenterStack secure file-sharing software suffers from an inadequately protected machine key vulnerability that can be used to modify ViewState data. This vulnerability may lead to remote code execution, which is already exploited. https://gladinetsupport.s3.us-east-1.amazonaws.com/gladinet/securityadvisory-cve-2005.pdf Google Patches two zero-day vulnerabilities CVE-2024-53150 CVE-2024-53197 Google released its monthly patches for Android. Two of the patched vulnerabilities are already exploited. One of them was used by Serbian law enforcement. https://www.malwarebytes.com/blog/news/2025/04/google-fixes-two-actively-exploited-zero-day-vulnerabilities-in-android Broadcom VMWare Tenzu Updates Broadcom released updates for VMWare Tenzu. Many vulnerabilities affect the backup component and allow for arbitrary command execution. https://support.broadcom.com/web/ecx/security-advisory? Windows 11 April Update ads inetpub directory The April Windows 11 update appears to create a new /inetpub directory. It is unclear why, and removing it appears to have no bad effects. https://www.bleepingcomputer.com/news/microsoft/windows-11-april-update-unexpectedly-creates-new-inetpub-folder/ WhatsApp File Type Confusion/Spoofing WhatsApp patched a file type confusion vulnerability. A victim may be tricked into downloading n https://www.whatsapp.com/security/advisories/2025/ SANS Critical AI Security Guidelines https://www.sans.org/mlp/critical-ai-security-guidelines

Arbitrators and counsel can use artificial intelligence to improve service quality and lessen work burden, but they also must deal with the ethical and professional implications. In this episode, Rebeca Mosquera, a Reed Smith associate and president of ArbitralWomen, interviews Benjamin Malek, a partner at T.H.E. Chambers and former chair of the Silicon Valley Arbitration and Mediation Center AI Task Force. They reveal insights and experiences on the current and future applications of AI in arbitration, the potential risks of bias and transparency, and the best practices and guidelines for the responsible integration of AI into dispute resolution. The duo discusses how AI is reshaping arbitration and what it means for arbitrators, counsel and parties. ----more---- Transcript: Intro: Hello, and welcome to Tech Law Talks, a podcast brought to you by Reed Smith's Emerging Technologies Group. In each episode of this podcast, we will discuss cutting-edge issues on technology, data, and the law. We will provide practical observations on a wide variety of technology and data topics to give you quick and actionable tips to address the issues you are dealing with every day.  Rebeca: Welcome to Tech Law Talks and our series on AI. My name is Rebeca Mosquera. I am an attorney with Reed Smith in New York focusing on international arbitration. Today we focus on AI in arbitration. How artificial intelligence is reshaping dispute resolution and the legal profession. Joining me is Benjamin Malek, a partner at THE Chambers and chair of the Silicon Valley Arbitration and Mediation Center AI Task Force. Ben has extensive experience in commercial and investor state arbitration and is at the forefront of AI governance in arbitration. He has worked at leading institutions and law firms, advising on the responsible integration of AI into dispute resolution. He's also founder and CEO of LexArb, an AI-driven case management software. Ben, welcome to Tech Law Talks.  Benjamin: Thank you, Rebeca, for having me.  Rebeca: Well, let's dive in into our questions today. So artificial intelligence is often misunderstood, or put it in other words, there is a lot of misconceptions surrounding AI. How would you define AI in arbitration? And why is it important to look beyond just generative AI?  Benjamin: Yes, thank you so much for having me. AI in arbitration has existed for many years now, But it hasn't been until the rise of generative AI that big question marks have started to arise. And that is mainly because generative AI creates or generates AI output, whereas up until now, it was a relatively mild output. I'll give you one example. Looking for an email in your inbox, that requires a certain amount of AI. Your spellcheck in Word has AI, and it has been used for many years without raising any eyebrows. It hasn't been until ChatGPT has really given an AI tool to the masses that question started arising. What can it do? Will attorneys still be held accountable? Will AI start drafting for them? What will happen? And it's that fear that started generating all this talk about AI. Now, to your question on looking beyond generative AI, I think that is a very important point. In my function as the chair of the SAMC AI Task Force, while we were drafting the guidelines on the use of AI, one of the proposals was to call it use of generative AI in arbitration. And I'm very happy that we stood firm and said no, because there's many forms of AI that will arise over the years. Now we're talking about predictive AI, but there are many AI forms such as predictive AI, NLP, automations, and more. And we use it not only in generating text per se, but we're using it in legal research, in case prediction to a certain extent. Whoever has used LexisNexis, they're using a new tool now where AI is leveraged to predict certain outcomes, document automation, procedural management, and more. So understanding AI as a whole is crucial for responsible adoption.  Rebeca: That's interesting. So you're saying, obviously, that AI and arbitration is more than just chat GPT, right? I think that the reason why people think that and relies on maybe, as we'll see in some of the questions I have for you, that people may rely on chat GPT because it sounds normal. It sounds like another person texting you, providing you with a lot of information. And sometimes we just, you know, people, I can understand or I can see why people might believe that that's the correct outcome. And you've given examples of how AI is already being used and that people might not realize it. So all of that is very interesting. Now, tell me, as chair of the SVAMC AI Task Force, you've led significant initiatives in AI governance, right? What motivated the creation of the SVAMC AI guidelines? And what are their key objectives? And before you dive into that, though, I want to take a moment to congratulate you and the rest of the task force on being nominated once again for the GAR Awards, which will be unveiled during Paris Arbitration Week in April of this year. That's an incredible achievement. And I really hope you'll take pride in the impact of your work and the well-deserved recognition it continues to receive. So good luck to you and the rest of the team.  Benjamin: Thank you, Rebeca. Thank you so much. It really means a lot, and it also reinforces the importance of our work, seeing that we're nominated not only once last year for the GAR Award, but second year in a row. I will be blunt, I haven't kept track of many nominations, but I think it may be one of the first years where one initiative gets nominated twice, one year after the other. So that in itself for us is worth priding ourselves with. And it may potentially even be more than an award itself. It really, it's a testament to the work we have provided. So what led to the creation of the SVAMC AI guidelines? It's a very straightforward and to a certain extent, a little boring answer as of now, because we've heard it so many times. But the crux was Mata versus Avianca. I'm not going to dive into the case. I think most of us have heard it. Who hasn't? There's many sources to find out about it. The idea being that in a court case, an attorney used Chad GPT, used the outcome without verifying it, and it caused a lot of backlash, not only from opposing party, but also being chastised by the judge. Now when I saw that case, and I saw the outcome, and I saw that there were several tangential cases throughout the U.S. And worldwide, I realized that it was only a question of time until something like this could potentially happen in arbitration. So I got on a call with my dear friend Gary Benton at the SVAMC, and I told him that I really think that this is the moment for the Silicon Valley Arbitration Mediation Center, an institution that is heavily invested in tech to shine. So I took it upon myself to say, give me 12 months and I'll come up with guidelines. So up until now at the SVAMC, there are a lot of think tank-like groups discussing many interesting subjects. But the SVAMC scope, especially AI related, was to have something that produces something tangible. So the guidelines to me were intuitive. It was, I will be honest, I don't think I was the only one. I might have just been the first mover, but there we were. We created the idea. It was vetted by the board. And we came up first with the task force, then with the guidelines. And there's a lot more to come. And I'll leave it there.  Rebeca: Well, that's very interesting. And I just wanted to mention or just kind of draw from, you mentioned the Mata case. And you explained a bit about what happened in that case. And I think that was, what, 2023? Is that right? 2022, 2023, right? And so, but just recently we had another one, right? In the federal courts of Wyoming. And I think about two days ago, the order came out from the judge and the attorneys involved were fined about $15,000 because of hallucinations on the case law that they cited to the court. So, you know I see that happening anyway. And this is a major law firm that we're talking about here in the U.S. So it's interesting how we still don't learn, I guess. That would be my take on that.  Benjamin: I mean, I will say this. Learning is a relative term because learning, you need to also fail. You need to make mistakes to learn. I guess the crux and the difference is that up until now, at any law firm or anyone working in law would never entrust a first-year associate, a summer associate, a paralegal to draft arguments or to draft certain parts of a pleading by themselves without supervision. However, now, given that AI sounds sophisticated, because it has unlimited access to words and dictionaries, people assume that it is right. And that is where the problem starts. So I am obviously, personally, I am no one to judge a case, no one to say what to do. And in my capacity of the chair of the SVAMC AI task force, we also take a backseat saying these are soft law guidelines. However, submitting documents with information that has not been verified has, in my opinion, very little to do with AI. It has something to do with ethical duty and candor. And that is something that, in my opinion, if a court wants to fine attorneys, they're more welcome to do so. But that is something that should definitely be referred to the Bar Association to take measures. But again, these are my two cents as a citizen.  Rebeca: No, very good. Very good. So, you know, drawing from that point as well, and because of the cautionary tales we hear about surrounding these cases and many others that we've heard, many see AI as a double-edged sword, right? On the one hand, offering efficiency gains while raising concerns about bias and procedural fairness. What do you see as the biggest risk and benefits of AI in arbitration?  Benjamin: So it's an interesting question. To a certain extent, we tried to address many of the risks in the AI guidelines. Whoever hasn't looked at the guidelines yet, I highly suggest you take a look at them they're available on svamc.org I'm sure that they're widely available on other databases Jus Mundi has it as well. I invite everyone to take a look at it. There are several challenges. We don't believe that those challenges would justify not using it. To name a few, we have bias. We have lack of transparency. We also have the issue of over-reliance, which is the one we were talking about just a minute ago, where it seems so sophisticated that we as human beings, having worked in the field, cannot conceive how such an eloquent answer is anything but true. So there's a black box problem and so many others, but quite frankly, there are so many benefits that come with it. AI is an unlimited knowledge tool that we can use. As of now, AI is what we know it is. It has hallucinations. It does have some bias. There is this black box problem. Where does it come from? Why? What's the source? But quite frankly, if we are able to triage the issues and to really look at what are the advantages and what is it we want to get out of it, and I'll give you a brief example. Let's say you're drafting an RFA. If you know the case, you know the parties, and you know every aspect of the case, AI can draft everything head to toe. You will always be able to tell what is from the case and what's not from the case. If we over-rely on AI and we allow it to draft without verifying all the facts, without making sure we know the transcript inside and out, without knowing the facts of the case, then we will always run into certain issues. Another issue we run into a lot with predictive AI is relying on data that exists. So compared to generative AI, predictive AI is taking data that already exists and predicting another outcome. So there's a lesser likelihood of hallucinations. The issue with that is, of course, bias. Just a brief example, you're the president of Arbitral Women, so you will definitely understand. It has only been in the last 30 years that women had more of a presence in arbitration, specifically sitting as an arbitrator. So if we rely on data that goes beyond those 30, 40, 50 years, there's going to be a lot of male decisions having been taken. Potentially even laws that applied back then that were not very gender neutral. So we need, we as people, need to triage and understand where is the good information, where is information that may have bias and counterbalance it. As of now, we will need to counterbalance it manually. However, as I always say, we've only seen a grain of salt of what AI can do. So as time progresses, the challenges, as you mentioned, will become lesser and lesser and lesser. And the knowledge that AI has will become wider and wider. As of now, especially in arbitration, we are really taking advantage of the fact that there is still scarcity of knowledge. But it is really just a question of time until AI picks up. So we need to get a better understanding of what is it we can do to leverage AI to make ourselves indispensable.  Rebeca: No, that's very interesting, Ben. And as you mentioned, yes, as president of ArbitralWomen, the word bias is something I pay close attention. You know, we're talking about bias. You mentioned bias. And we all have conscious or unconscious biases, right? And so you mentioned that about laws that were passed in the past where potentially there was not a lot of input from women or other members of our society. Do you think AI can be trained then to be truly neutral or will bias always be a challenge?  Benjamin: I wish I had the right answer. I think, I actually truly believe that bias is a very relative term. And in certain societies, bias has a very firm and black and white standing, whereas in other societies, it does not. Especially in international arbitration, where we not only deal with cross-border disputes, but different cultures, different laws, laws of the seats, laws of the contract. I think it's very hard to point out one set of bias that we will combat or that we will set as principle for everything. I think ultimately what ensures that there is always human oversight in the use of AI, especially in arbitration, are exactly these type of issues. So we can, of course, try to combat bias and gender bias and others. But I don't think it is as easy as we say, because even nowadays, in normal proceedings, we are still dealing with bias on a human level. So I think we cannot ask from machines to be less biased than we as humans are.  Rebeca: Let me pivot here a bit. And, you know, earlier, we mentioned the GAR Awards. And now I'd like to shift our focus to the recent GAR Life on Technology that took place here in New York last week on February 20th. And to give our audience, you know, some context. GAR stands for Global Arbitration Review, a widely read journal that not only ranks international arbitration practices at law firms worldwide, but also, among other things, organizes live conferences on cutting-edge topics in arbitration across the globe. So I know you were a speaker at GAR Live, and there was an important discussion about distinguishing generative AI, predictive AI, and other AI applications. How do these different AI technologies impact arbitration, and how do the SVAMC guidelines address them?  Benjamin: I was truly honored to speak at the GAR Live event in New York, and I think the fact that I was invited to speak on AI as a testament on how important AI is and how widely interested the community is in the use of AI, which is very different to 2023 when we were drafting the guidelines on the use of AI. I think it is important to understand that ultimately, everything in arbitration, specifically in arbitration, needs human oversight. But in using AI in arbitration, I think we need to differentiate on how the use of AI is different in arbitration versus other parts of the law, and specifically how it is different in arbitration compared to how we would use it on a day-to-day basis. In arbitration specifically, arbitrators are still responsible for a personal or arbitrators are given a personal mandate that is very different to how law works in general. Where you have a lot of judges that let their assistants draft parts of the decision, parts of the order. Arbitration is a little different, and that for a reason. Specifically in international arbitration, because there are certain sensitivities when it comes to local law, when it comes to an international standard and local standards. Arbitrators are held to a higher standard. Using AI as an arbitrator, for example, which could technically be put at the same level as using a tribunal secretary, has its limits. So I think that AI can be used in many aspects, from drafting for attorneys, for counsel, when it comes to helping prepare graphs, when it comes to preparing documents, accumulating documents, etc., etc. But it does have its limits when it comes to arbitrators using it. As we have tried to reiterate in the guidelines, arbitrators need to be very conscious of where their personal mandate starts and ends. In other words, our recommendation, again, we are soft law guidelines, our recommendation to arbitrators are to not use AI when it comes to any decision-making process. What does that mean? We don't know. And neither does the law. And every jurisdiction has their own definition of what that means. It is up for the arbitrator to define what a decision-making process is and to decide of whether the use of AI in that process is adequate.  Rebeca: Thank you so much, Ben. I want to now kind of pivot, since we've been talking a little bit more about the guidelines, I want to ask you a few questions about them. So they were created with a global perspective, right? And so what initiatives is the AI task force pursuing to ensure the guidelines remain relevant worldwide? You've been talking about different legal systems and local laws and how practitioners or certain regulations within certain jurisdictions might treat certain things differently. So what is the AI task force doing to remain relevant, to maybe create some sort of uniformity? So what can you tell me about that?  Benjamin: So we at the SVAMC task force, we continue to gather feedback, of course, And we're looking for global adaptation. We will continue to work closely with practitioners, with institutions, with lawmakers, with government, to ensure that when it comes to arbitration, AI is given a space, it's used adequately, and if possible, of course, and preferential to us, the SVAMC AI guidelines are used. That's why they were drafted, to be used. When we presented the guidelines to different committees and to different law sections and bar associations, it struck us that jurisdictions such as the U.S., and more specifically in New York, where both you and I are based, the community was not very open to receiving these guidelines as guidelines. And the suggestion was actually made to creating a white paper, And as much as it seemed to be a shutdown at an early stage, when we were thinking about it, and I was very blessed to have seven additional members in the Guidelines Drafting Committee, seven very bright individual members that I learned a lot from during this process. It was clear to us that jurisdictions such as New York have a very high ethical standard, and where guidelines such as our guidelines would potentially be seen as doubling ethical rules. So although we advocate for them not being ethical guidelines whatsoever, because we don't believe they are, we strongly suggest that local and international ethical standards are being upheld. So with that in mind, we realize that there is more to a global aspect that needs to be addressed rather than an aspect of law associations in the US or in the UK or now in Europe. Up-and-coming jurisdictions that up until now did not have a lot of exposure to artificial intelligence and maybe even technology as a whole are rising. And they may need more guidance than jurisdictions where technology may be an instinct away. So what the AI task force has created. And is continuing to recruit for, are regional committees for the AI Task Force, tracking AI usage in different legal systems and different jurisdictions. Our goal is to track AI-related legislation and its potential impact on arbitration. These regional committees will also provide jurisdiction-specific insights to refine the guidelines. And hopefully, or this is what we anticipate, these regional committees will help bridge the gap between AI's global development and local legal framework. There will be a dialogue. We will continue, obviously, to be present at conferences, to have open dialogue, and to recruit, of course, for these committees. But the next step is definitely to focus on these regional committees and to see how we, as the AI task force of the Silicon Valley Arbitration Mediation Center, can impact the use of AI in arbitration worldwide.  Rebeca: Well, that's very interesting. So you're utilizing committees in different jurisdictions to keep you appraised of what's happening in each jurisdiction. And then with that, continue, you know, somehow evolving the guidelines and gathering information to see how this field, you know, it's changing rapidly.  Benjamin: Absolutely. Initially, we were thinking of just having a small local committee to analyze different jurisdictions and what laws and what court cases, etc. But we soon came to realize that it's much more than tracking judicial decisions. We need people on the ground that are part of a jurisdiction, part of that local law, to tell us how AI impacts their day-to-day, how it may differ from yesterday to tomorrow, and what potential legislation will be enacted to either allow or disallow the use of certain AI.  Rebeca: That's very interesting. I think it's something that will keep the guidelines up to date and relevant for a long time. So kudos to you, the SVAMC and the task force. Now, I know that the guidelines are a very short paper, you know, and then in the back you have the commentary on them. So I want to, I'm not going to dissect all of the guidelines, but I want to come and talk about one of them in particular that I think created a lot of discussion around the guidelines itself. So for full disclosure, right, I was part of the reviewing committee of the AI guidelines. And I remember that one of the most debated aspects of the SVAMC AI guidelines is guideline three on disclosure, right? So should arbitrators and counsel disclose their AI use in proceedings? So I think that that has generated a lot of debates. And that's the reason why we have the resulting guideline number three, the way it is drafted. So can you give us a little bit more of insight what happened there?  Benjamin: Absolutely. I'd love to. Guideline three was very controversial from the get-go. We initially had two options. We had a two-pronged test that parties would either satisfy or not, and then disclosure was necessary. And then we had another option that the community could vote on where it was up to the parties to decide whether their AI-aided submission could impact the outcome of the case. And depending on that, they would disclose or not disclose whether AI was used. Quite frankly, that was a debate we had in 2023, and a lot changed from November 2023 until April, when we finally published the first version of the AI guidelines. A lot of courts have implemented an obligatory disclosure. I think people have also gotten more comfortable with using AI on a day-to-day. And we ultimately came to the conclusion to opt for a flexible disclosure approach, which can now be found in the guidelines. The reason for that was relatively simple, or relatively simple to us who debated that. Having a disclosure obligation of the use of AI will very easily become inefficient for two reasons. A blanket disclosure for the use of AI serves nobody. It really boils down to one question, which is, if the judge, or in our case in arbitration, if the arbitrator or tribunal knows that AI was used for a certain document, now what? How does that knowledge transform into action? And how does that knowledge lead to a different outcome? And in our analysis, it turned out that a blanket disclosure of AI usage, or in general, an over-disclosure of the use of AI in arbitration, may actually lead to adverse consequences for the parties who make the disclosure. Why? Because not knowing how AI can impact these submissions causes arbitrators not to know what to do with that disclosure. So ultimately, it's really up to the parties to decide, how was AI used? How can it impact the case? What is it I want to disclose? How do I disclose? It's also important for the arbitrators to understand, what do I do with the disclosure before saying, everything needs to be disclosed. During the GAR event in New York, the issue was raised whether documents which were prepared with the use of AI should be disclosed or whether there should be a blanket disclosure. And quite frankly, the debate went back and forth, but ultimately it comes down to cross-examination. It comes down to the expert or the party submitting the document, being able to back up where the information comes from rather than knowing that AI was used. And if you put that in aspect, we received a very interesting question of why we should continue using AI, knowing that approximately 30% of its output are hallucinations and it needs revamping. This was compared to a summer associate or a first-year associate, and the question was very simple. If I have a first-year associate or a summer associate whose output has a 30% error rate, why would I continue using that associate? And quite frankly, there is merit to the question, and it really has a very simple answer. And the answer is time and money. Using AI makes it much faster to receive using AI makes it faster to receive output than using a first year associate or summer associate and it's way cheaper. For that, it's worth having a 30% error margin. I don't know where they got the 30% from, but we just went along with it.  Rebeca: I was about to ask you where they get the 30%. And well, I think that for first-year associates or summer associates that are listening, I think that the main thing will be for them to then become very savvy in the use of AI so they can become relevant to the practice. I think everyone, you know, there's always that question about whether AI will replace all of us, the entire world, and we'll go into machine apocalypses. I don't see it that way. In my view, I see that if we, you know, if we train ourselves, if we're not afraid of using the tool, we'll very much be in a position to pivot and understand how to use it. And when you have, what is the saying, garbage in, garbage out. So if you have a bad input, you will have a bad output. You need to know the case. You need to know your documents to understand whether the machine is hallucinating or giving you, you know, an information that is not real. I like to play and ask certain questions to chat GPT, you know, here and there. And sometimes I, you know, I ask obviously things that I know the answer to. And then I'm like, chat GPT, this is not accurate. Can you check on this? And he's like, oh, thank you for correcting me. I mean, and it's just a way of, you got to try and understand it so you know where to make improvements. But that doesn't mean that the tool, because it's a tool, will come and replace, you know, your better judgment as a professional, as an attorney.  Benjamin: Absolutely. One of the things we say is it is a tool. It does nothing out of its own volition. So what you're saying is 100% right. This is what the SVAMC AI guidelines stand for. Practitioners need to accustom themselves on proper use of AI. AI can be used from paid versions to unpaid versions. We just need to understand what is an open source AI, what is a close circuit AI. Again, for whoever's listening, feel free to look up the guidelines. There's a lot of information there. There's tons of articles written at this point. And just be very mindful of if there is an open AI system, such as an unpaid chat GPT version. It does not mean you cannot use it. First, check with your firm to make sure you're allowed to use it. I don't want to get into any trouble.  Rebeca: Well, we don't want to put confidential information on an open AI platform.  Benjamin: Exactly. Once the firm or your colleagues allow you to use ChatGPT, even if it's an open version, just be very smart about what it is you're putting in. No confidential information, no potential conflict check, no potential cases. Just be smart about what it is you put in. Another aspect we were actually debating about is this hallucination. Just an example, let's say you say this is an ISDS case, so we're talking a little more public, and you ask Chad GPT, hey, show me all the cases against Costa Rica. And it hallucinates, too. It might actually be that somebody input information for a potential case against Costa Rica or a theoretical case against Costa Rica, Chad GPT being on the open end, takes that as one potential case. So just be very smart. Be diligent, but also don't be afraid of using it.  Rebeca: That's a great note to end on. AI is here to stay. And as legal professionals, it's up to us to ensure it serves the interests of justice, fairness, and efficiency. And for those interested in learning more about the SVAMC AI guidelines, you can find them online at svamc.org and search for guidelines. I tried it myself and you will go directly to the guidelines. And if you like to stay updated on developments in AI and arbitration, be sure to follow Tech Law Talks and join us for future episodes where we'll continue exploring the intersection of law and technology. Ben, thank you again for joining me today. It's been a great pleasure. And thank you to our listeners for tuning in.  Benjamin: Thank you so much, Rebeca, for having me and Tech Law Talks for the opportunity to be here.  Outro: Tech Law Talks is a Reed Smith production. Our producers are Ali McCardell and Shannon Ryan. For more information about Reed Smith's Emerging Technologies Practice, please email techlawtalks@reedsmith.com. You can find our podcasts on Spotify, Apple Podcasts, Google Podcasts, reedsmith.com, and our social media accounts.  Disclaimer: This podcast is provided for educational purposes. It does not constitute legal advice and is not intended to establish an attorney-client relationship, nor is it intended to suggest or establish standards of care applicable to particular lawyers in any given situation. Prior results do not guarantee a similar outcome. Any views, opinions, or comments made by any external guest speaker are not to be attributed to Reed Smith LLP or its individual lawyers.  All rights reserved. Transcript is auto-generated.

When life feels overwhelming, finding contentment in the simple things and seeking God's guidance can transform frustration into peace.

Dr. Ko Un “Clara” Park and Dr. Mylin Torres present the latest evidence-based changes to the SLNB in early-stage breast cancer guideline. They discuss the practice-changing trials that led to the updated recommendations and topics such as when SLNB can be omitted, when ALND is indicated, radiation and systemic treatment decisions after SLNB omission, and the role of SLNB in special circumstances. We discuss the importance of shared decision-making and other ongoing and future de-escalation trials that will expand knowledge in this space. Read the full guideline update, “Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update” at www.asco.org/breast-cancer-guidelines. TRANSCRIPT This guideline, clinical tools, and resources are available at http://www.asco.org/breast-cancer-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology, https://ascopubs.org/doi/10.1200/JCO-25-00099       Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges and advances in oncology. You can find all the shows, including this one at asco.org/podcasts. My name is Brittany Harvey and today I'm interviewing Dr. Ko Un "Clara" Park from Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Dr. Mylin Torres from Glenn Family Breast Center at Winship Cancer Institute of Emory University, co-chairs on “Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update.” Thank you for being here today, Dr. Park and Dr. Torres. Dr. Mylin Torres: Thank you, it's a pleasure to be here. Brittany Harvey: And before we discuss this guideline, I'd like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO Conflict of Interest Policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Torres and Dr. Park, who have joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. To start us off, Dr. Torres, what is the scope and purpose of this guideline update on the use of sentinel lymph node biopsy in early-stage breast cancer? Dr. Mylin Torres: The update includes recommendations incorporating findings from trials released since our last published guideline in 2017. It includes data from nine randomized trials comparing sentinel lymph node biopsy alone versus sentinel lymph node biopsy with a completion axillary lymph node dissection. And notably, and probably the primary reason for motivating this update, are two trials comparing sentinel lymph node biopsy with no axillary surgery, all of which were published from 2016 to 2024. We believe these latter two trials are practice changing and are important for our community to know about so that it can be implemented and essentially represent a change in treatment paradigms. Brittany Harvey: It's great to hear about these practice changing trials and how that will impact these recommendation updates. So Dr. Park, I'd like to start by reviewing the key recommendations across all of these six overarching clinical questions that the guideline addressed. So first, are there patients where sentinel lymph node biopsy can be omitted? Dr. Ko Un "Clara" Park: Yes. The key change in the current management of early-stage breast cancer is the inclusion of omission of sentinel lymph node biopsy in patients with small, less than 2 cm breast cancer and a negative finding on preoperative axillary ultrasound. The patients who are eligible for omission of sentinel lymph node biopsy according to the SOUND and INSEMA trial are patients with invasive ductal carcinoma that is size smaller than 2 cm, Nottingham grades 1 and 2, hormone receptor-positive, HER2-negative in patients intending to receive adjuvant endocrine therapy, and no suspicious lymph nodes on axillary ultrasound or if they have only one suspicious lymph node, then the biopsy of that lymph node is benign and concordant according to the axillary ultrasound findings. The patients who are eligible for sentinel lymph node biopsy omission according to the SOUND and INSEMA trials were patients who are undergoing lumpectomy followed by whole breast radiation, especially in patients who are younger than 65 years of age. For patients who are 65 years or older, they also qualify for omission of sentinel lymph node biopsy in addition to consideration for radiation therapy omission according to the PRIME II and CALGB 9343 clinical trials. And so in those patients, a more shared decision-making approach with the radiation oncologist is encouraged. Brittany Harvey: Understood. I appreciate you outlining that criteria for when sentinel lymph node biopsy can be omitted and when shared decision making is appropriate as well. So then, Dr. Torres, in those patients where sentinel lymph node biopsy is omitted, how are radiation and systemic treatment decisions impacted? Dr. Mylin Torres: Thank you for that question. I think there will be a lot of consternation brought up as far as sentinel lymph node biopsy and the value it could provide in terms of knowing whether that lymph node is involved or not. But as stated, sentinel lymph node biopsy actually can be safely omitted in patients with low risk disease and therefore the reason we state this is that in both SOUND and INSEMA trial, 85% of patients who had a preoperative axillary ultrasound that did not show any signs of a suspicious lymph node also had no lymph nodes involved at the time of sentinel node biopsy. So 85% of the time the preoperative ultrasound is correct. So given the number of patients where preoperative ultrasound predicts for no sentinel node involvement, we have stated within the guideline that radiation and systemic treatment decisions should not be altered in the select patients with low risk disease where sentinel lymph node biopsy can be omitted. Those are the patients who are postmenopausal and age 50 or older who have negative findings on preoperative ultrasound with grade 1 or 2 disease, small tumors less than or equal to 2 cm, hormone receptor-positive, HER2-negative breast cancer who undergo breast conserving therapy. Now, it's important to note in both the INSEMA and SOUND trials, the vast majority of patients received whole breast radiation. In fact, within the INSEMA trial, partial breast irradiation was not allowed. The SOUND trial did allow partial breast irradiation, but in that study, 80% of patients still received whole breast treatment. Therefore, the preponderance of data does support whole breast irradiation when you go strictly by the way the SOUND and INSEMA trials were conducted. Notably, however, most of the patients in these studies had node-negative disease and had low risk features to their primary tumors and would have been eligible for partial breast irradiation by the ASTRO Guidelines for partial breast treatment. So, given the fact that 85% of patients will have node-negative disease after a preoperative ultrasound, essentially what we're saying is that partial breast irradiation may be offered in these patients where omission of sentinel node biopsy is felt to be safe, which is in these low risk patients. Additionally, regional nodal irradiation is something that is not indicated in the vast majority of patients where omission of sentinel lymph node biopsy is prescribed and recommended, and that is because very few of these patients will actually end up having pathologic N2 disease, which is four or more positive lymph nodes. If you look at the numbers from both the INSEMA and the SOUND trial, the number of patients with pathologic N2 disease who did have their axilla surgically staged, it was less than 1% in both trials. So, in these patients, regional nodal irradiation, there would be no clear indication for that more aggressive and more extensive radiation treatment. The same principles apply to systemic therapy. As the vast majority of these patients are going to have node-negative disease with a low risk primary tumor, we know that postmenopausal women, even if they're found to have one to three positive lymph nodes, a lot of the systemic cytotoxic chemotherapy decisions are driven by genomic assay score which is taken from the primary tumor. And therefore nodal information in patients who have N1 disease may not be gained in patients where omission of sentinel lymph node biopsy is indicated in these low risk patients. 14% of patients have 1 to 3 positive lymph nodes in the SOUND trial and that number is about 15% in the INSEMA trial. Really only the clinically actionable information to be gained is if a patient has four or more lymph nodes or N2 disease in this low risk patient population. So, essentially when that occurs it's less than 1% of the time in these patients with very favorable primary tumors. And therefore we thought it was acceptable to stand by a recommendation of not altering systemic therapy or radiation recommendations based on omission of sentinel nodes because the likelihood of having four more lymph nodes is so low. Dr. Ko Un "Clara" Park: I think one thing to add is the use of CDK4/6 inhibitors to that and when we look at the NATALEE criteria for ribociclib in particular, where node-negative patients were included, the bulk majority of the patients who were actually represented in the NATALEE study were stage III disease. And for stage I disease to upstage into anatomic stage III, that patient would need to have pathologic N2 disease. And as Dr. Torres stated, the rate of having pathologic N2 disease in both SOUND and INSEMA studies were less than 1%. And therefore it would be highly unlikely that these patients would be eligible just based on tumor size and characteristics for ribociclib. So we think that it is still safe to omit sentinel lymph node biopsy and they would not miss out, if you will, on the opportunity for CDK4/6 inhibitors. Brittany Harvey: Absolutely. I appreciate you describing those recommendations and then also the nuances of the evidence that's underpinning those recommendations, I think that's important for listeners. So Dr. Park, the next clinical question addresses patients with clinically node negative early stage breast cancer who have 1 or 2 sentinel lymph node metastases and who will receive breast conserving surgery with whole breast radiation therapy. For these patients, is axillary lymph node dissection needed? Dr. Ko Un "Clara" Park: No. And this is confirmed based on the ACOSOG Z0011 study that demonstrated in patients with 1 to 3 positive sentinel lymph node biopsy when the study compared completion axillary lymph node dissection to no completion axillary lymph node dissection, there was no difference. And actually, the 10-year overall survival as reported out in 2017 and at a median follow up of 9.3 years, the overall survival again for patients treated with sentinel lymph node biopsy alone versus those who were treated with axillary lymph node dissection was no different. It was 86.3% in sentinel lymph node biopsy versus 83.6% and the p-value was non-inferior at 0.02. And so we believe that it is safe for the select patients who are early stage with 1 to 2 positive lymph nodes on sentinel lymph node biopsy, undergoing whole breast radiation therapy to omit completion of axillary lymph node dissection. Brittany Harvey: Great, I appreciate you detailing what's recommended there as well. So then, to continue our discussion of axillary lymph node dissection, Dr. Torres, for patients with nodal metastases who will undergo mastectomy, is axillary lymph node dissection indicated? Dr. Mylin Torres: It's actually not and this is confirmed by two trials, the AMAROS study as well as the SENOMAC trial. And in both studies, they compared a full lymph node dissection versus sentinel lymph node biopsy alone in patients who are found to have 1 to 2 positive lymph nodes and confirmed that there was no difference in axillary recurrence rates, overall survival or disease-free survival. What was shown is that with more aggressive surgery completion axillary lymph node dissection, there were higher rates of morbidity including lymphedema, shoulder pain and paresthesias and arm numbness, decreased functioning of the arm and so there was only downside to doing a full lymph node dissection. Importantly, in both trials, if a full lymph node dissection was not done in the arm that where sentinel lymph node biopsy was done alone, all patients were prescribed post mastectomy radiation and regional nodal treatment and therefore both studies currently support the use of post mastectomy radiation and regional nodal treatment when a full lymph node dissection is not performed in these patients who are found to have N1 disease after a sentinel node biopsy. Brittany Harvey: Thank you. And then Dr. Park, for patients with early-stage breast cancer who do not have nodal metastases, can completion axillary lymph node dissection be omitted? Dr. Ko Un "Clara" Park: Yes, and this is an unchanged recommendation from the earlier ASCO Guidelines from 2017 as well as the 2021 joint guideline with Ontario Health, wherein patients with clinically node-negative early stage breast cancer, the staging of the axilla can be performed through sentinel lymph nodal biopsy and not completion axillary lymph node dissection. Brittany Harvey: Understood. So then, to wrap us up on the clinical questions here, Dr. Park, what is recommended regarding sentinel lymph node biopsy in special circumstances in populations? Dr. Ko Un "Clara" Park: One key highlight of the special populations is the use of sentinel lymph node biopsy for evaluation of the axilla in clinically node negative multicentric tumors. While there are no randomized clinical trials evaluating specifically the role of sentinel lymph nodal biopsy in multicentric tumors, in the guideline, we highlight this as one of the safe options for staging of the axilla and also for pregnant patients, these special circumstances, it is safe to perform sentinel lymph node biopsy in pregnant patients with the use of technetium - blue dye should be avoided in this population. In particular, I want to highlight where sentinel lymph node biopsy should not be used for staging of the axilla and that is in the population with inflammatory breast cancer. There are currently no studies demonstrating that sentinel lymph node biopsy is oncologically safe or accurate in patients with inflammatory breast cancer. And so, unfortunately, in this population, even after neoadjuvant systemic therapy, if they have a great response, the current guideline recommends mastectomy with axillary lymph node dissection. Brittany Harvey: Absolutely. I appreciate your viewing both where sentinel lymph node can be offered in these special circumstances in populations and where it really should not be used. So then, Dr. Torres, you talked at the beginning about how there's been these new practice changing trials that really impacted these recommendations. So in your view, what is the importance of this guideline update and how does it impact both clinicians and patients? Dr. Mylin Torres: Thank you for that question. This update and these trials that inform the update represent a significant shift in the treatment paradigm and standard of care for breast cancer patients with early-stage breast cancer. When you think about it, it seems almost counterintuitive that physicians and patients would not want to know if a lymph node is involved with cancer or not through sentinel lymph node biopsy procedure. But what these studies show is that preoperative axillary ultrasound, 85% of the time when it's negative, will correctly predict whether a sentinel lymph node is involved with cancer or not and will also be negative. So if you have imaging that's negative, your surgery is likely going to be negative. Some people might ask, what's the harm in doing a sentinel lymph node biopsy? It's important to recognize that upwards of 10% of patients, even after sentinel lymph node biopsy will develop lymphedema, chronic arm pain, shoulder immobility and arm immobility. And these can have a profound impact on quality of life. And if there is not a significant benefit to assessing lymph nodes, particularly in someone who has a preoperative axillary ultrasound that's negative, then why put a patient at risk for these morbidities that can impact them lifelong? Ideally, the adoption of omission of sentinel lymph node biopsy will lead to more multidisciplinary discussion and collaboration in the preoperative setting especially with our diagnostic physicians, radiology to assure that these patients are getting an axillary ultrasound and determine how omission of sentinel lymph node biopsy may impact the downstream treatments after surgery, particularly radiation and systemic therapy decisions, and will be adopted in real world patients, and how clinically we can develop a workflow where together we can make the best decisions for our patients in collaboration with them through shared decision making. Brittany Harvey: Absolutely. It's great to have these evidence-based updates for clinicians and patients to review and refer back to. So then finally, Dr. Park, looking to the future, what are the outstanding questions and ongoing trials regarding sentinel lymph node biopsy in early-stage breast cancer? Dr. Ko Un "Clara" Park: I think to toggle on Dr. Torres's comment about shared decision making, the emphasis on that I think will become even more evident in the future as we incorporate different types of de-escalation clinical studies. In particular, because as you saw in the SOUND and INSEMA studies, when we de-escalate one modality of the multimodality therapy, i.e., surgery, the other modalities such as radiation therapy and systemic therapy were “controlled” where we were not de-escalating multiple different modalities. However, as the audience may be familiar with, there are other types of de-escalation studies in particular radiation therapy, partial breast irradiation or omission of radiation therapy, and in those studies, the surgery is now controlled where oftentimes the patients are undergoing surgical axillary staging. And conversely when we're looking at endocrine therapy versus radiation therapy clinical trials, in those studies also the majority of the patients are undergoing surgical axillary staging. And so now as those studies demonstrate the oncologic safety of omission of a particular therapy, we will be in a position of more balancing of the data of trying to select which patients are the safe patients for omission of certain types of modality, and how do we balance whether it's surgery, radiation therapy, systemic therapy, endocrine therapy. And that's where as Dr. Torres stated, the shared decision making will become critically important. I'm a surgeon and so as a surgeon, I get to see the patients oftentimes first, especially when they have early-stage breast cancer. And so I could I guess be “selfish” and just do whatever I think is correct. But whatever the surgeon does, the decision does have consequences in the downstream decision making. And so the field really needs to, as Dr. Torres stated earlier, rethink the workflow of how early-stage breast cancer patients are brought forth and managed as a multidisciplinary team. I also think in future studies the expansion of the data to larger tumors, T3, in particular,reater than 5 cm and also how do we incorporate omission in that population will become more evident as we learn more about the oncologic safety of omitting sentinel lymph node biopsy. Dr. Mylin Torres: In addition, there are other outstanding ongoing clinical trials that are accruing patients right now. They include the BOOG 2013-08 study, SOAPET, NAUTILUS and the VENUS trials, all looking at patients with clinical T1, T2N0 disease and whether omission of sentinel lymph node biopsy is safe with various endpoints including regional recurrence, invasive disease-free survival and distant disease-free survival. I expect in addition to these studies there will be more studies ongoing even looking at the omission of sentinel lymph node biopsy in the post-neoadjuvant chemotherapy setting. And as our imaging improves in the future, there will be more studies improving other imaging modalities, probably in addition to axillary ultrasound in an attempt to accurately characterize whether lymph nodes within axilla contain cancer or not, and in that context whether omission of sentinel lymph node biopsy even in patients with larger tumors post-neoadjuvant chemotherapy may be done safely and could eventually become another shift in our treatment paradigm. Brittany Harvey: Yes. The shared decision making is key as we think about these updates to improve quality of life and we'll await data from these ongoing trials to inform future updates to this guideline. So I want to thank you both so much for your extensive work to update this guideline and thank you for your time today. Dr. Park and Dr. Torres. Dr. Mylin Torres: Thank you. Dr. Ko Un "Clara" Park: Thank you. Brittany Harvey: And thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/breast-cancer-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app available in the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

Are “contact lens veneers” just fake news? Why is the traditional 0.7mm prep approach outdated? Are you truly preserving enamel in your veneer preparations? Should you ever bond veneers to root dentin or cementum after crown lengthening? Why is the Galip Gürel technique the gold standard for minimal prep veneers? https://youtu.be/5BEFD1XaZtE Watch PDP219 on Youtube Dr. David Bloom joins Jaz for an insightful episode, sharing his 36 years of experience in cosmetic and restorative dentistry. With over two decades in the same practice, he's seen what works—and what leads to failure—when it comes to veneers. We also cover the key steps in mock-ups, planning, and veneer preparation. Protrusive Dental Pearl:  Always Wax Up for 10: When planning veneers, start with a 10-unit wax-up (even if the patient initially wants 4 or 6). This allows them to visualize their full smile with a mock-up, compare different options, and make an informed decision. It's not about upselling - most patients will appreciate the fuller look. Key Take-aways: Health and diagnosis are foundational in cosmetic dentistry. Visual try-ins are crucial for patient engagement and satisfaction. Minimally invasive techniques are preferred for cosmetic procedures. Communication with patients about their options is essential. Bonding to enamel is more reliable than bonding to dentin. Permission statements help in guiding patient expectations. The transition from veneers to crowns should be carefully considered. Staining is not the primary concern when bonding to dentin. A change in surface texture is key in modern dental preparations. Visual aids are crucial in helping patients understand their treatment options. The Gurel technique emphasizes minimal preparation for veneers. Effective communication with patients can enhance their treatment experience. Understanding occlusion is fundamental in aesthetic dentistry. Veneer thickness should be as minimal as possible for aesthetic results. Patient involvement in the design process is essential. Cementation techniques can vary based on gingival health. Maintaining a facial path of insertion is important for aesthetic outcomes. Building a good relationship with lab technicians is key to successful restorations. Need to Read it? Check out the Full Episode Transcript below! Highlights of this episode: 02:56  Protrusive Dental Pearl 04:15 Interview with Dr. David Bloom: Journey and Expertise 11:54 The Importance of Enamel in Veneer Longevity 13:46 Prepless Cases and Visual Try-Ins 18:54  Permission Statement 22:24 Visual Try-Ins Protocol 25:13 Decision-Making: Veneers vs. Crowns 28:35 Bonding to Root Dentine and Long-Term Outcomes 33:34 Opening Embrasures: Techniques and Tips 35:19 Visual Try-Ins and Patient Communication 38:50 Wax-up in Occlusion 41:25 The Gurel Technique Explained 47:09 Black Triangles  49:40 Guidelines for First Veneer Case 54:10 Contact Lens Veneers 56:18 Cementation Preferences and Techniques 01:00:15 Final Thoughts and Educational Resources Need expert guidance on veneers and smile design? Join Intaglio Mentoring and connect with top mentors for real-time case support and level up your Dentistry. Dr David Bloom is also a mentor on Intaglio. Watch this space for David's new educational website coming soon - he teaches Veneers hands-on too. If you loved this episode, make sure to watch How to Temporise Veneers Step by Step FULL GUIDE – PDP214 This episode is eligible for 1 CE credit via the quiz on Protrusive Guidance.  This episode meets GDC Outcomes B and C. AGD Subject Code: 780 ESTHETICS/COSMETICDENTISTRY (Tooth colored restorations) #PDPMainEpisodes #AdhesiveDentistry Aim: To provide an in-depth understanding of minimal preparation veneers, focusing on enamel preservation, diagnostic workflows, patient communication,

While it's not as well-known as the GLP-1 drugs for weight loss, there's a medication option we want to discuss in this episode. Specifically, we're taking a deep dive into the topic of low-dose naltrexone -- known as LDN -- for weight management and autoimmune conditions, especially Hashimoto's thyroiditis, the leading cause of hypothyroidism in the United States. We'll look at how this medication works, the potential benefits for thyroid patients, such as reducing inflammation and antibodies, dosages, side effects, and patient experiences. You'll also hear expert insights from Paloma Health on the history and practical use of LDN for thyroid and autoimmune disease and weight loss. We'll also explore remission in Hashimoto's and hypothyroidism, outlining various strategies to get there, including medication optimization, dietary changes like the gluten-free or AIP diets, supplements, and the use of LDN. So, don't miss a chance to dive into this important topic with expert insights and practical advice from Paloma Health!Learn more with these in-depth resources from Paloma Health:Could Contrave Help Hypothyroid Patients Lose Weight?https://www.palomahealth.com/learn/contrave-hypothyroid-lose-weight Guidelines on Taking Low Dose Naltrexone for Hashimoto'shttps://www.palomahealth.com/learn/important-guidelines-taking-low-dose-naltrexone-ldn-hashimotos Hashimoto's Disease and TPO Antibodieshttps://www.palomahealth.com/learn/hashimotos-disease-tpo-antibodies LDN: Treatment for Hypothyroidism and Hashimoto'shttps://www.palomahealth.com/guides/ldn-treatment Low Dose Naltrexone (LDN), Hashimoto's, and Hypothyroidismhttps://www.palomahealth.com/learn/low-dose-naltrexone-hashimotos-hypothyroidism Low Dose Naltrexone for Hypothyroidism Weight Losshttps://www.palomahealth.com/learn/low-dose-naltrexone-hypothyroidism-weight-loss Low-Dose Naltrexone for Hashimoto'shttps://www.palomahealth.com/learn/naltrexone-hashimotos Remission in Hashimoto's Disease and Hypothyroidismhttps://www.palomahealth.com/learn/remission-hashimotos-disease-hypothyroidism Speaker Series: Low Dose Naltrexone (LDN) for Hashimoto's and Hypothyroidismhttps://www.youtube.com/watch?v=VBysQrZ3bKc About Paloma Health:⁠⁠Paloma Health⁠⁠⁠⁠⁠⁠⁠⁠is an online medical practice focused exclusively on treating hypothyroidism. From online visits with your provider to easy prescription management and lab orders, we create personalized treatment plans for you. Become a member⁠, or try our at-home test kit and experience a whole new level of hypothyroid care. Use code PODCAST to save $30 at checkout.Disclaimer: The $30 discount is only valid for first-time Paloma Health members and test kit users. Coupon must be entered at the time of checkout. Become a Paloma Member:https://www.palomahealth.com/pricing-hypothyroidism Paloma Complete Thyroid Blood Test Kit:https://www.palomahealth.com/home-thyroid-blood-test-kit 

In this episode of the International Enneagram Association podcast, we listen to a talk from Renee Rosario about using mindfulness with the Enneagram to gain greater clarity with what's happening inside. Mindfulness is a great tool to transform things and opens us up to greater wisdom. Renee explains the three skills that are essential to mindfulness—concentration, sensory clarity and equanimity—and how this can help us make better choices and develop new pathways before leading the group in an inner practice. She then invites a panel consisting of two people from each center—heart, head and body—to share what they noticed when they work with mindfulness and their bodies.Connect with us:Web: internationalenneagram.org2025 IEA Global Conference: internationalenneagram.org/2025-iea-global-conferenceJoin the email list: administration@internationalenneagram.orgIEA Conference Proposal Submission Information & Guidelines: internationalenneagram.org/wp-content/uploads/2024/07/2025-Proposal-Submission-Information-Guidelines.pdfIEA Global Podcast Proposal Submission Form: forms.gle/Q48QXSwQ3zDfDJaJARenee Rosario:Web: enneasight.comWeb: narrativeenneagram.orgAephoria Partners:Web: aephoriapartners.comFB: Aephoria Partners Consulting

In episode 124, host Jon Wood speaks with AORN Senior Perioperative Practice Specialist Amber Wood about how AORN Guidelines address numerous pertinent topics related to Sterile Processing, including challenges associated with 3D-printed instruments, short-cycle sterilization, overcrowded sets, and more. This podcast answers many questions you may not have even known to ask. Earn CE Now

Episode one of four on Paediatric ENT conditions. Doctors Lisa and Sara are joined by Paediatric Ear Nose and Throat Consultant Dr Simone Schaefer for this episode on Recurrent Acute Otitis Media (AOM) in Children. A common problem, we take a classic presentation and work through getting the diagnosis right, red flags and differentials before discussing management and which children may need referrals. We then discuss the limited options of what might be done in an ENT clinic and helpful resources for families.   You can use these podcasts as part of your CPD - we don't do certificates but they still count :) Useful Resources: NICE Clinical Knowledge Summaries on Acute Otitis Media (including initial presentation, persistent infections and recurrent infections (updated August 2024): https://cks.nice.org.uk/topics/otitis-media-acute/ Hoberman et al. 2021 NEJM Tympanostomy tube placement or medical management for recurrent acute otitis media: https://www.nejm.org/doi/full/10.1056/NEJMoa2027278 Resource for Patients: https://www.nhs.uk/conditions/ear-infections/ https://www.hopkinsmedicine.org/health/conditions-and-diseases/ear-infections-in-babies-and-toddlers ENT UK: Decision making aid for parents re Grommets: https://www.entuk.org/patients/conditions/5/grommets_a_decisionmaking_aid_for_parents ENT UK: Explainer leaflets, How to use ear drops or sprays: https://www.entuk.org/patients/conditions/74/how_to_use_ear_drops_or_sprays The Royal Children's Hospital Melbourne. Clinical Paediatric Guideline (good algorithm, pictures of erythematous Tympanic Membranes versus Acute Otitis Media with bulging/effusion): https://www.rch.org.au/clinicalguide/guideline_index/acute_otitis_media/ ENT Guidelines for Derbyshire (includes details of Topical Drops in specific cases: https://www.derbyshiremedicinesmanagement.nhs.uk/assets/Clinical_Guidelines/Formulary_by_BNF_chapter_prescribing_guidelines/BNF_chapter_12/Chapter_12_Ear_nose_and_oropharynx.pdf ___ We really want to make these episodes relevant and helpful: if you have any questions or want any particular areas covered then contact us on Twitter @PCKBpodcast, or leave a comment on our quick anonymous survey here: https://pckb.org/feedback Email us at: primarycarepodcasts@gmail.com ___ This podcast has been made with the support of GP Excellence and Greater Manchester Integrated Care Board. Given that it is recorded with Greater Manchester clinicians, the information discussed may not be applicable elsewhere and it is important to consult local guidelines before making any treatment decisions.  The information presented is the personal opinion of the healthcare professional interviewed and might not be representative to all clinicians. It is based on their interpretation of current best practice and guidelines when the episode was recorded. Guidelines can change; To the best of our knowledge the information in this episode is up to date as of it's release but it is the listeners responsibility to review the information and make sure it is still up to date when they listen. Dr Lisa Adams, Dr Sara MacDermott and their interviewees are not liable for any advice, investigations, course of treatment, diagnosis or any other information, services or products listeners might pursue as a result of listening to this podcast - it is the clinicians responsibility to appraise the information given and review local and national guidelines before making treatment decisions. Reliance on information provided in this podcast is solely at the listeners risk. The podcast is designed to be used by trained healthcare professionals for education only. We do not recommend these for patients or the general public and they are not to be used as a method of diagnosis, opinion, treatment or medical advice for the general public. Do not delay seeking medical advice based on the information contained in this podcast. If you have questions regarding your health or feel you may have a medical condition then promptly seek the opinion of a trained healthcare professional.

Join Dr. John Abramson and Robert Whitaker as they evaluate the trustworthiness of clinical trials and medical data. Understand the importance of reliable data in making informed health decisions. #ClinicalTrials #MedicalData #HealthEvidence

The Baseball America Fantasy Podcast returns for another week and we're talking strategy this week on the show. Host Dylan White breaks down some important guidelines to follow for dynasty managers. We also talk all the news and notes of the last week in MLB and the minors. (1:00) Vladimir Guerrero Jr. contract reaction.(8:00) Chase Burns debut reaction(20:00) Nick Kurtz is on fire.(28:00) Chase Dollander debut(32:00) George Kirby timeline.(34:00) Thomas Saggese callup(41:00) Tyler Soderstrom breakout is this real?(45:00) Most important guidelines to follow in dynasty.Our Sponsors:* Check out Indeed: https://indeed.com/BASEBALLAMERICASupport this podcast at — https://redcircle.com/baseball-america/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Happy April! This month for the April 2025 episode of the RCEM Learning Podcast we have Andy and Dave talking about the use of beta-blockers in sepsis. Becky and Chris talking about mortality reviews in the ED. In a similarly patient-safety aligned topic I speak to Maegan Ladell talking about patient safety culture and then finally, as always, New Online. If you'd like to email us, please feel free to do so here. After listening, complete a short quiz to have your time accredited for CPD at the RCEMLearning website! (01:47) New in EM - Beta blockers in sepsis Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP) (Rehberg et al., 2024) (16:34) Guidelines for EM - Mortality reviews in the ED RCEM - Mortality Reviews in the ED (RCEM, 2025) [PDF] (49:26) Patient Safety Culture - Meagen Ladell The problem with how we view medical (and diagnostic) error in emergency medicine (Ladell et al., 2025) SEIPS 101 and seven simple SEIPS tools (Holden and Carayon, 2021) (01:12:16) New Online – new articles on RCEMLearning for your CPD Combatting the Crowd - Peter Fielding Ovarian Hyperstimulation Syndrome - Thomas Mac Mahon Curriculum Cup: Ophthalmology - RCEMLearning

See all the Healthcasts at https://www.biobalancehealth.com/healthcast-blog I am not sure if you play THE “WHAT'S THE DISEASE THAT I DON'T WANT TO HAVE GAME with yourself, but since I am a doctor I have spent a lot of time thinking about what diseases I do not want! I started my list in medical school when I witnessed what certain diseases can do to your life.  Medicine has many cures and treatments, yet some diseases that are treated still can negatively change your life forever. Even though losing a limb and amputation were at the top of my list there is one disease that tops my list.  Of course, I also have under stroke the usual scary situations like paralysis, or having an incapacitating heart attack that prevents an individual from taking care of himself or herself. However, my most feared diagnosis is having a STROKE! You may not fully comprehend how a stroke can change your life, but it can affect your speech, your ability to move, to think, to go places, to have a sense of humor, to write and communicate, even to have a sexual relationship with your loved one. A stroke essentially can take away your ability to be the person you have always been, AND it requires that someone must become your caretaker.  That helplessness is something I am most afraid of….We all have our personal fears, but whether you fear having a stroke or not, you should  try your hardest to avoid having one! DEFINITION: a stoke is a medical emergency that occurs when blood flow to the brain is  blocked or a blood vessel bursts. This can damage or kill parts of the brain, which can lead to long-term disability, brain damage, or even death.  This can cause s a loss of function, physical, mental, and  emotional, and loss of one or more of the senses like sensation, speech, sight, hearing and  taste and smell! In my practice at BioBalance Health we always work with our patients to prevent them having a stroke and or heart attack. These two conditions are the biggest villains that steal the joy of our “golden years” from us.  From the start of my BioBalance Health practice, I have incorporated  healthy diet training, exercise options and encouragement, how and what to take to supplement my patients' diet and how to outsmart their genetic makeup so they can be healthier than their parents. All of these lifestyle changes can decrease the risk of stroke and heart attack in a person. So what is it like to have a stroke? First let's go over what symptoms are typical of someone having a stroke. The symptoms of a stroke are multiple, and a person might not have all of them. Weakness on one side of the body Facial drooping on one side of the face Dizziness Numbness Loss of balance Sudden loss of vision. Trouble making sense when speaking Trouble talking, reading or understanding Sudden nausea and vomiting Brief loss of consciousness such as fainting, seizures, confusion, or coma. When someone has one or more of these symptoms it is an emergency, and you should call 911, then start asking the patient to open their eyes, smile, raise both arms and hold them up. Ask them to talk to see if their speech is impaired. Your findings will be helpful to the EMTs who come to the scene. An event is called a stroke, when there is a deficit in physical or mental function and that deficit continues and doesn't go away.  If it the symptoms completely resolve, it is called a TIA- a transient Ischemic attack. It is a warning to see a doctor and make sure you don't have a stroke in the future and it is a wakeup call to stop all poor lifestyle choices.   PREVENTING A STROKE: This last month, the American Heart and Stroke prevention Association released new Guidelines on how to prevent a stroke.  I think talking about the risk factors for stroke and discussing how to prevent having one, is worthy of discussion. Recently the medical guidelines for stroke prevention have been revised, and even though I think a few more things should have been included, the fact that they made the first change in the guidelines in 10 years is a first step. Here is what they advise all people who are aging should do.   #1 See your internal medicine or Family physician regularly, at least yearly #2. Stop sedentary behavior—walk/exercise/ do Yoga, just get out of the chair for the majority of your day! #3. If you are diabetic, they advocate going on Ozempic/Mounjaro to lose weight—that will lower your risk of a stroke, and heart attack.. #4 If you are hypertensive, take your BP medicine every day #5 Follow these lifestyle changes called Life's Essential 8: Your behavior and lifestyle put you at risk for having a stroke:    Healthy diet, low carb Mediterranean diet, no junk food!  Physical activity every day  Achieve a healthy weight,  Make sure your sleep is restful  Stop use of tobacco products, No smoking or vaping  Achieve healthy levels of blood glucose, and blood pressure.  Don't drink more than one 4 oz glass of wine a day  I add these recommendations to theirs for the care of my patients:   Drink ½ your weight in water every day Wat at least half your weight in grams of protein a day Get a Cardiac calcium scan to see if you have arterial plaque. If you do have plaque (arteriosclerosis) then you are at risk for stroke as well. See a cardiologist to be treated preventatively and tested. Option other than a cardiac calcium scan, get a carotid ultrasound to make sure you don't have plaque in the neck vessels that lead to your brain.. Make sure your Homocysteine level is normal (

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3555: Minimalism isn't about having a perfectly curated aesthetic, it's about removing distractions to focus on what truly matters. Anthony Ongaro shares ten simple guidelines for embracing a minimalist lifestyle, emphasizing decluttering before organizing, letting go of the pursuit of things, and detaching self-worth from possessions. Whether you're new to minimalism or refining your approach, these insights make intentional living feel more achievable. Read along with the original article(s) here: https://www.breakthetwitch.com/minimalism-guidelines/ Quotes to ponder: "It doesn't need to cost you anything. Embracing minimalism in your life doesn't mean buying new things that have a certain minimalistic aesthetic." "Minimalism isn't a one-time project. What minimalism looks like for you will change as your needs and lifestyle change." "Minimalism isn't about living an easier life. It may be simple, but it's not easy." Episode references: Becoming Minimalist: https://www.becomingminimalist.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3555: Minimalism isn't about having a perfectly curated aesthetic, it's about removing distractions to focus on what truly matters. Anthony Ongaro shares ten simple guidelines for embracing a minimalist lifestyle, emphasizing decluttering before organizing, letting go of the pursuit of things, and detaching self-worth from possessions. Whether you're new to minimalism or refining your approach, these insights make intentional living feel more achievable. Read along with the original article(s) here: https://www.breakthetwitch.com/minimalism-guidelines/ Quotes to ponder: "It doesn't need to cost you anything. Embracing minimalism in your life doesn't mean buying new things that have a certain minimalistic aesthetic." "Minimalism isn't a one-time project. What minimalism looks like for you will change as your needs and lifestyle change." "Minimalism isn't about living an easier life. It may be simple, but it's not easy." Episode references: Becoming Minimalist: https://www.becomingminimalist.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3555: Minimalism isn't about having a perfectly curated aesthetic, it's about removing distractions to focus on what truly matters. Anthony Ongaro shares ten simple guidelines for embracing a minimalist lifestyle, emphasizing decluttering before organizing, letting go of the pursuit of things, and detaching self-worth from possessions. Whether you're new to minimalism or refining your approach, these insights make intentional living feel more achievable. Read along with the original article(s) here: https://www.breakthetwitch.com/minimalism-guidelines/ Quotes to ponder: "It doesn't need to cost you anything. Embracing minimalism in your life doesn't mean buying new things that have a certain minimalistic aesthetic." "Minimalism isn't a one-time project. What minimalism looks like for you will change as your needs and lifestyle change." "Minimalism isn't about living an easier life. It may be simple, but it's not easy." Episode references: Becoming Minimalist: https://www.becomingminimalist.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome back to the BH Sales Kennel Kelp Holistic Healing Hour and YouTube Channel@billholt8792 Today, I wanted to take a moment to clarify and discuss the nature of our online forums. As many of you know, these spaces are designed to foster community, share information, and support each other on our holistic healing journeys.It's important to understand that our forums are not open marketplaces for direct advertising or the display of goods. While we deeply value and appreciate the presence of business proprietors from around the world, and I personally welcome them on this podcast to share their expertise, the forums themselves maintain a focus on community interaction rather than commercial promotion.This distinction is crucial for maintaining the integrity of our community and ensuring that the primary purpose remains the exchange of knowledge and support. We believe that by creating a space free from overt advertising, we can cultivate a more authentic and meaningful experience for all members.However, I recognize the importance of connecting our community with valuable resources. That's why I'm dedicated to featuring business owners and experts on this podcast. Here, we can explore their offerings in a conversational and informative way, allowing you to learn more about the products and services that may benefit your holistic journey.We appreciate your understanding and cooperation in upholding these guidelines. Our goal is to create a harmonious and supportive environment for everyone. Thank you for being a part of our community."#HolisticHealing,#OnlineCommunity,#ForumGuidelines,#CommunitySupport,#BusinessSpotlight,#PodcastInterview,#PeacefulDiscussion,#CommunityIntegrity,#OnlineEtiquette,#HolisticWellness,Navigating Our Community: Forum Guidelines and Business SpotlightsBuilding a Supportive Space: Understanding Our Forum's PurposeCommunity First: Clarifying Our Forum's Approach to BusinessHolistic Harmony: Balancing Community and Business on Our ForumsThe Heart of Our Forums: A Conversation on Guidelines and CollaborationFostering Community: Understanding the purpose of our online forum#GrandpaBillsWellnessWisdom,#HolisticHealingJourney,#AlternativeHealth,#NaturalWellness,#IntegrativeMedicine,#MeditationGuidance,#RetirementGoals,#GivingBack#GoodwillAmbassador#InformationalPodcast#EducatedChoices#LikeMindedCommunity#BillHoltPodcast#BHSalesKennelKelp

In today's episode, host Dr. Jay Sridhar is joined by Dr. Bobeck Modjtahedi to discuss the American Academy of Ophthalmology's new guidelines on autoimmune retinopathy (AIR), recently published in Ophthalmology Retina. A member of the Academy's task force on AIR and lead author, Dr. Modjtahedi discusses a new diagnostic framework for categorizing AIR as probable, possible, or unlikely based on specific clinical criteria. The guidelines address the challenges in diagnosing this rare condition that mimics inherited retinal diseases, and outline a standardized approach to classification for both clinical practice and research. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Fr. Alex Goussetis speaks with Fr Peter Spiro, Director of the GOA National Human Trafficking Awareness Ministry, on who are the traffickers, who are the victims, and what parents need to know to protect their children.

When it comes to worshipping God, remember to follow his guidelines—and not yours. -------- Thank you for listening! Your support of Joni and Friends helps make this show possible.     Joni and Friends envisions a world where every person with a disability finds hope, dignity, and their place in the body of Christ. Become part of the global movement today at www.joniandfriends.org   Find more encouragement on Instagram, TikTok, Facebook, and YouTube.

PREVIEW: #OZWATCH: Banning cricket talk; amateur guidelines. Jeremy Zakis, New South Wales. #FriendsOfHistoryDebatingSociety. 1920 AUSTRALIA. https://au.news.yahoo.com/queensland-cricket-imposes-shock-ban-after-storm-around-usman-khawaja-in-sheffield-shield-204321713.html

Hematuria remains one of the most common urologic diagnoses, estimated to account for over 20% of urology evaluations. Women with hematuria have been especially prone to delays in evaluation, often due to practitioners ascribing hematuria to a urinary tract infection (UTI) or gynecologic source, resulting in inadequate evaluation and delay in cancer diagnosis. In this episode, we will review the recently released joint guidance form the AUA and SUFU regarding microhematuria. What defines this condition? If a UTI is also diagnosed, does that end the investigation? And what are the 3 risk profiles for microhematuria? Listen in for details!

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education. Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence Educational Objectives Examine best practices for optimizing medication adherence and treatment initiation in hypercholesterolemia management Explain patient education and counseling for managing hypercholesteremia Faculty: Joseph Saseen, PharmD, BCPS, BCACP, CLS Professor and Associate Dean for Clinical Affairs University of Colorado Anschutz Medical Campus Skaggs School of Pharmacy and Pharmaceutical Sciences Aurora, Colorado   Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Executive Director, Ambulatory Pharmacy Services Grady Health System Atlanta, Georgia Joseph Saseen, PharmD, BCPS, BCACP, CLS, has the following financial relationships with commercial interests to disclose: Other Support (Lipid Monitoring Committee): Amgen (VESALIUS and OCEAN(a))   Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA, has the following financial relationships with commercial interests to disclose: Grant/Research Support: Novartis Consultant: Novartis, Regeneron   Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-9999-25-069-H01-P. The activity is available for CE credit through March 31, 2026.   This activity is jointly provided by the University of Connecticut School of Pharmacy–Storrs and Pharmacy Times Continuing Education™, and is supported by an educational grant from Novartis Pharmaceuticals Corporation.   Please follow the link below to access this activity on PTCE and claim CE credit: www.pharmacytimes.org/hyperlipidemiapodcast

As industry standards and guidelines evolve, are your department's workflows keeping up? In this week's new episode from our “Safe and Sterile Endoscopes” series, Stacy Johnson and Melanie Marshall, Clinical Education Consultants at ASP, join us to break down the latest regulatory requirements, including AAMI ST91, and their impact on endoscope reprocessing workflows. From FDA recommendations to evidence-based standards, these education experts outline what these changes mean for your department. Whether you're preparing for your next audit or updating outdated processes, this episode provides the clarity and tools you need to stay ahead. Tune in now to take the next step toward safer and smarter reprocessing practices! This dynamic 6-part series explores the critical world of endoscope innovation, design, and safety. Each episode will feature insights from industry leaders and clinical experts who are transforming the way we approach scope safety and sterility. From frontline technicians to department leaders, this series will equip your team with powerful strategies to transform your reprocessing workflows! A special thanks to our sponsor, Advanced Sterilization Products (ASP), for making this series possible! Their commitment to education and quality in endoscope care has been instrumental in bringing this series to life. Visit our CE Credit Hub at https://www.beyondcleanmedia.com/ce-credit-hub to access this quiz and over 350 other free CE credits.  #BeyondClean #ASP #Endoscopes #SterileProcessing #ScopeSafety #Podcast *This episode is currently pending 1 CE approval with HSPA & CBSPD. Please check back next week for access to this quiz and your CE certificate.